Joel Harris
email: joel@genvax.com
phone: 515-686-4676
Title(s)
CEO
Genvax Technologies
Office
2503 South Loop Drive, Suite 5446 Ames, IA 50010-8641
Information
Research interest: Genvax Technologies is developing herd-specific, prescription vaccines for the livestock industry, with an initial focus on swine influenza and African swine fever. In addition to his veterinary industry work as co-founder and CEO of Genvax Technologies, Harris also serves as Executive Director for the Ag Startup Engine, a seed program in Ames, IA. He was Business Development Manager for Vitalize Venture Group, a venture capital investment firm in Chicago. He held COO, CIO, and Vice President roles at Harrisvaccines, an international animal health vaccines company that he and his father Dr. Hank Harris sold to Merck Animal Health in 2015. Harris has a B.A. in Economics from the University of Iowa and a Post-baccalaureate Certificate in Narrative Communications from Northwestern University.